암 바이오마커 시장 : 바이오마커 유형별, 암 유형별, 프로파일링 기술별, 최종 용도별, 지역별

Global Cancer Biomarkers Market is estimated to be valued at USD 28.90 Bn in 2025 and is expected to reach USD 67.62 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.9% from 2025 to 2032.

Figure. Cancer Biomarkers Market Share (%), By Region 2025

Cancer biomarkers are biological molecules found in blood, tissues or other body fluids that are sign of a normal or abnormal process, or of a condition or disease. These can be used to detect and monitor cancer or cancer progression. In recent years, cancer biomarkers have gained significant attention from both global public and private organizations as these present minimally invasive ways to diagnose, stage and track cancer. Their use also enables oncologists to personalize treatments based on individual patient's cancer profiles. Advancements in genetic profiling and high-throughput technologies have unlocked the potential of biomarkers that can predict treatment responses and disease progression more accurately. This has promising implications for improving cancer care globally.

Market Dynamics:

Global cancer biomarkers market growth is driven by rising cancer prevalence worldwide, increasing popularity of precision medicine and companion diagnostics, and growing use of biomarkers in drug development as well as approvals. However, high costs associated with biomarker discovery, validation, and commercialization pose a challenge. Moreover, technical limitations and lack of reimbursements restrain the market growth. The market witnesses lucrative opportunities from emerging economies with large cancer populations and growing health expenditures. Further opportunities lie in discovery of novel biomarkers especially for hard-to-treat cancers through ongoing research efforts.

Key Features of the Study:

• This report provides in-depth analysis of the global cancer biomarkers market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cancer biomarkers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study includes bioMerieux Inc., INOVIQ, Bio-Rad Laboratories Inc., Abbott, Becton Dickinson and Company, Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific Inc., CENTOGENE N.V., PerkinElmer Inc., Siemens Healthineers, F. Hoffmann-la Roche Ltd, Agilent Technologies, Inc, Invitae Corporation, Myriad Genetics, Guardant Health, Illumina, and FOUNDATION MEDICINE, INC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global cancer biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer biomarkers market

Detailed Segmentation-

• Biomarker Type:
  • CA 125
  • HER2
  • EGFR
  • CD20
  • BRAF
  • Calcitonin
  • Others
• Cancer Type
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Kidney Cancer
  • Liver Cancer
  • Head & neck Cancer
  • Non-small Cell Lung Cancer
  • Other Cancers
• Profiling Technology:
  • OMICS Technology
  • Imaging Technology
  • Immunoassays
  • Cytogenetics
  • Others
• End User:
  • Hospitals
  • Specialty Clinics
  • Diagnostic Laboratories
  • Academic Research Institutes
  • Others
• Regional:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • bioMerieux Inc.
  • INOVIQ
  • Bio-Rad Laboratories Inc.
  • Abbott
  • Becton Dickinson and Company
  • Merck KgaA
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • CENTOGENE N.V.
  • PerkinElmer Inc.
  • Siemens Healthineers
  • Hoffmann-la Roche Ltd
  • Agilent Technologies, Inc
  • Invitae Corporation
  • Myriad Genetics
  • Guardant Health
  • Illumina
  • FOUNDATION MEDICINE, INC.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Biomarker Type
  • Market Snapshot, By Cancer Type
  • Market Snapshot, By Profiling Technology
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• PEST Analysis

4. Global Cancer Biomarkers Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Impact on Supply and Demand
• COVID-19 Impact on the market

5. Global Cancer Biomarkers Market, By Biomarker Type, 2020 - 2032, (USD BN)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• CA 125
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• HER2
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• EGFR
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• CD20
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• BRAF
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Calcitonin
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

6. Global Cancer Biomarkers Market, By Cancer Type, 2020 - 2032, (USD BN)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Breast Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Lung Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Prostate Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Kidney Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Liver Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Head & neck Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Non-small Cell Lung Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Other Cancers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

7. Global Cancer Biomarkers Market, By End User, 2020 - 2032, (USD BN)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• OMICS Technology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Imaging Technology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Immunoassays
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Cytogenetics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

8. Global Cancer Biomarkers Market, By End User, 2020 - 2032, (USD BN)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Specialty Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Diagnostic Laboratories
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Academic & Research Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

9. Global Cancer Biomarkers Market, By Region, 2020 - 2032, (USD BN)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

• bioMerieux, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• INOVIQ
• Bio-Rad Laboratories, Inc.
• Abbott
• Becton, Dickinson and Company
• Merck KGaA
• QIAGEN
• Thermo Fisher Scientific Inc.
• CENTOGENE N.V.
• PerkinElmer Inc.
• Siemens Healthineers
• F. Hoffmann-la Roche Ltd
• Agilent Technologies, Inc
• Invitae Corporation
• Myriad Genetics
• Guardant Health
• Illumina
• FOUNDATION MEDICINE, INC.

11. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact